Competing views on cancer

Journal of Biosciences

Volumn 39, Issue 2, 2014, Pages 281-302

  Sonnenschein, Carlos ^a,b   Soto, Ana M ^a,b   Rangarajan, Annapoorni ^c   Kulkarni, Prakash ^d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c INDIAN INSTITUTE OF SCIENCE   (India)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Histogenesis; Intrinsically disordered proteins; Morphogenesis; Protein interaction network; Stroma epithelium interaction; Tissue organization field theory

Indexed keywords

MYC PROTEIN; INTRINSICALLY DISORDERED PROTEIN;

CANCER; CELL ORGANELLE; DISEASE INCIDENCE; HISTOLOGY; MORPHOGENESIS; PHILOSOPHY; PROTEIN; RESEARCH WORK;

CANCER STEM CELL; CARCINOGENESIS; CELL FUNCTION; CELL INTERACTION; CELL MOTILITY; CELL PROLIFERATION; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NEOPLASM; NONHUMAN; PROTEIN INTERACTION; REVIEW; TISSUE INTERACTION; TISSUE STRUCTURE; TUMOR PROMOTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; MUTATION; NEOPLASMS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; HUMANS; INTRINSICALLY DISORDERED PROTEINS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; NEOPLASTIC STEM CELLS;

EID: 84904208474     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-013-9403-y     Document Type: Review

References (169)

1. Alberts B 2010 Model organisms and human health. Science 330 1724
2. Alberts B, Bray D, Lewis JG, Raff M, Roberts K and Watson JD 1994 Molecular biology of the cell 4th edition (New York, NY: Garland Publishing Inc.) p 891
3. Alberts B, Johnson A, Lewis J, RaffM, Roberts K and Walter P 2002 Molecular biology of the cell 5th edition (London: Garland Science) p 1015
4. Alberts B, Johnson A, Lewis J, Raff M, Roberts K and Walter P 2008 Molecular biology of the cell (London: Garland Science)
5. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF 2003 Prospective identification of tumorigenic breast cancer cells. Proc. Acad. Natl. Acad. Sci. USA 100 3983-3988 (Pubitemid 36418143)
6. Alison MR, Lin WR, Lim SM and Nicholson LJ 2012 Cancer stem cells: in the line of fire. Cancer Treat. Rev. 38 589-598
7. Allegrucci C, Rushton MD, Dixon JE, Sottile V, Shah M, Kumari R, Watson S, Alberio R and Johnson AD 2011 Epigenetic reprogramming of breast cancer cells with oocyte extracts. Mol. Cancer 10 7
8. Anurag M and Dash D 2009 Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosis. Mol. Biosyst. 5 1752-1757
9. Aoki Y, Niihori T, Narumi Y, Kure S and Matsubara Y 2008 The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum. Mutat. 29 992-1006
10. Axelrod R, Axelrod DE and Pienta KJ 2006 Evolution of cooperation among tumor cells. Proc. Acad. Natl. Acad. Sci. USA 103 13474-13479 (Pubitemid 44380132)
11. Ayala FJ 1968 Biology as an autonomous science. Am. Sci. 56 207-221
12. Baccelli I and Trumpp A 2012 The evolving concept of cancer and metastasis stem cells. J. Cell Biol. 198 281-93
13. Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, et al. 2013 Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay. Nat. Biotechnol. 31 539-44
14. Baker SG 2012 Paradoxes in carcinogenesis should spur new avenues of research: an historical perspective. Disrup. Sci. Technol. 1 100-107
15. Baker SG and Kramer BS 2007 Paradoxes in carcinogenesis: new opportunities for research directions. BMC Cancer 7 151
16. Baker SG, Soto AM, Sonnenschein C, Cappuccio A, Potter JD and Kramer BS 2009 Plausibility of stromal initiation of epithelial cancers without a mutation in the epithelium: a computer simulation of morphostats. BMC Cancer 9 89
17. Baldwin JM 1896 A new factor in evolution. Am. Nat. 30 441-451
18. Barcellos-Hoff MH and Ravani SA 2000 Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60 1254-1260 (Pubitemid 30151992)
19. Baylin SB 2011 Resistance, epigenetics and the cancer ecosystem. Nat. Med. 17 288-289
20. Beh LY, Colwell LJ and Francis NJ 2012 A core subunit of Polycomb repressive complex 1 is broadly conserved in function but not primary sequence. Proc. Acad. Natl. Acad. Sci. USA 109 E1063-E1071
21. Behera N and Nanjundiah V 1995 An investigation into the role of phenotypic plasticity in evolution. J. Theor. Biol. 172 225-234 (Pubitemid 26447560)
22. Behera N and Nanjundiah V 1996 The consequences of phenotypic plasticity in cyclically varying environments: a genetic algorithm study. J. Theor. Biol. 178 135-144 (Pubitemid 26118843)
23. Behera N and Nanjundiah V 2004 Phenotypic plasticity can potentiate rapid evolutionary change. J. Theor. Biol. 226 177-184 (Pubitemid 37468396)
24. Ben-Jacob E, Coffey DS and Levine H 2012 Bacterial survival strategies suggest rethinking cancer cooperativity. Trends Microbiol. 20 403-410
25. Bhowmick NA, Neilson EG and Moses HL 2004 Stromal fibroblasts in cancer initiation and progression. Nature 432 332-337 (Pubitemid 39551661)
26. Biggs A 2003 Biology: The dynamics of life (Glencoe/McGraw-Hill)
27. Bissell MJ and Radisky D 2001 Putting tumours in context. Nat. Rev. Cancer 1 46-54 (Pubitemid 33741880)
28. Bizzarri M, Cucina A, Biava PM, Proietti S, D'Anselmi F, Dinicola S, Pasqualato A and Lisi E 2011 Embryonic morphogenetic field induces phenotypic reversion in cancer cells. Curr. Pharm. Biotechnol. 12 243-253
29. Bizzarri M, Pasqualato A, Cucina A and Pasta V 2013 Physical forces and non-linear dynamics mould fractal cell shape: quantitative morphological parameters and cell phenotype. Histol. Histopathol. 28 155-274
30. Bonnet D and Dick JE 1997 Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat. Med. 3 730-737 (Pubitemid 27298715)
31. Booth BW, Boulanger CA anderson LH and Smith GH 2011 The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene 30 679-869
32. Boveri T 1929 The origin of malignant tumors (Baltimore: Williams & Wilkins)
33. Brabletz T, Jung A, Spaderna S, Hlubek F and Kirchner T 2005 Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression. Nat. Rev. Cancer 5 744-749 (Pubitemid 41486367)
34. Bussard KM, Boulanger CA, Booth BW, Bruno RD and Smith GH 2010 Reprogramming human cancer cells in the mouse mammary gland. Cancer Res. 70 6336-6343
35. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, et al. 2011 Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc. Acad. Natl. Acad. Sci. USA 108 7950-7955
36. Chao MP, Seita J and Weissman IL 2008 Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb. Symp. Quant. Biol. 73 439-449
37. Chao MP, Weissman IL and Majeti R 2012 The CD47-SIRPalpha pathway in cancer immune evasion and potential therapeutic implications. Curr. Opin. Immunol. 24 225-232
38. Cho RW and Clarke MF 2008 Recent advances in cancer stem cells. Curr. Opin. Genet. Dev. 18 48-53 (Pubitemid 351694448)
39. Coussens LM, Zitvogel L and Palucka AK 2013 Neutralizing tumor-promoting chronic inflammation: a magic bullet? Science 339 286-91
40. Cumberworth A, Lamour G, Babu MM and Gsponer J 2013 Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes. Biochem. J. 454 361-369
41. Dalerba P, Cho RW and Clarke MF 2007 Cancer stem cells: models and concepts. Annu. Rev. Med. 58 267-284 (Pubitemid 46706514)
42. Darwin C 1909 Origin of species (New York: P.F. Collier & Son)
43. Dean M, Fojo T and Bates S 2005 Tumour stem cells and drug resistance. Nat. Rev. Cancer 5 275-84 (Pubitemid 40488633)
44. Deves M and Bourrat F 2012 Transcriptional mechanisms of developmental cell cycle arrest: problems and models. Semin. Cell Dev. Biol. 23 290-297
45. Duesberg P, Li R, Fabarius A and Hehlmann R 2006 Aneuploidy and cancer: from correlation to causation. Contrib. Microbiol. 13 16-44
46. Eldredge N and Gould SJ 1972 Punctuated equilibria: an alternative to phyletic gradualism. Models Paleobiol. 82 115
47. Elenbaas B, Spirio L, Koerner F, Fleming MD, Zimonjic DB, Donaher JL, Popescu NC, Hahn WC and Weinberg RA 2001 Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 15 50-65
48. Esteller M 2008 Epigenetics in cancer. New Engl. J. Med. 358 1148-59
49. Fillmore C and Kuperwasser C 2007 Human breast cancer stem cell markers CD44 and CD24: enriching for cells with functional properties in mice or in man. Breast Cancer Res. 9 303
50. Fisher R, Pusztai L and Swanton C 2013 Cancer heterogeneity: implications for targeted therapeutics. Brit. J. Cancer 108 479-85
51. Fleck L 1981 Genesis and development of a scientific fact (Chicago: University of Chicago Press)
52. Follis AV, Galea CA and Kriwacki RW 2012 Intrinsic protein flexibility in regulation of cell proliferation: advantages for signaling and opportunities for novel therapeutics. Adv. Exp. Med. Biol. 725 27-49
53. Fong YW, Inouye C, Yamaguchi T, Cattoglio C, Grubisic I and Tjian R 2011 ADNA repair complex functions as an Oct4/Sox2 coactivator in embryonic stem cells. Cell 147 120-131
54. Franklin RE and Gosling RG 1953 Molecular configuration in sodium thymonucleate. Nature 171 740-741
55. Georgiades IB, Curtis LJ, Morris RM, Bird CC and Wyllie AH 1999 Heterogeneity studies identify a subset of sporadic colorectal cancers without evidence for chromosomal or microsatellite instability. Oncogene 18 7933-7940 (Pubitemid 30050553)
56. Goodell MA, Brose K, Paradis G, Conner AS and Mulligan RC 1996 Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183 1797-1806 (Pubitemid 26134320)
57. Griffin JL and Kauppinen RA 2007 Tumour metabolomics in animal models of human cancer. J. Proteome Res. 6 498-505 (Pubitemid 46340153)
58. Gupta PB, Chaffer CL, Weinberg RA 2009 Cancer stem cells: mirage or reality? Nat. Med. 15 1010-1012
59. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C and Lander ES 2011 Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146 633-44
60. Hahn WC and Weinberg RA 2002 Modelling the molecular circuitry of cancer. Nat. Rev. Cancer 2 331-341 (Pubitemid 37328946)
61. Hanahan D and Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70 (Pubitemid 30046295)
62. Hanahan D and Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674
63. Harley CB, Kim NW, Prowse KR, Weinrich SL, Hirsch KS, West MD, Bacchetti S, Hirte HW, Counter CM, Greider CW, et al. 1994 Telomerase, cell immortality and cancer. Cold Spring Harb. Symp. Quant. Biol. 59 307-315
64. Harris H 2007 Concerning the origin of malignant tumours (Cold Spring Harbor Laboratory Press)
65. Hendrix MJ, Seftor EA, Seftor RE, Kasemeier-Kulesa J, Kulesa PM and Postovit LM 2007 Reprogramming metastatic tumour cells with embryonic microenvironments. Nat. Rev. Cancer 7 246-55 (Pubitemid 46480969)
66. Hinton GE and Nowlan SJ 1987 How learning can guide evolution. Complex Syst. 1 495-502
67. Huang S 2012 Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution. Prog. Biophys. Mol. Biol. 110 69-86
68. Huang S 2013 When peers are not peers and don't know it: The Dunning-Kruger effect and self-fulfilling prophecy in peer-review. BioEssays: News Rev. Mol. Cell. Dev. Biol. 35 414-416
69. Huang S and Ingber DE 2006 A non-genetic basis for cancer progression and metastasis: self-organizing attractors in cell regulatory networks. Breast Dis. 26 27-54 (Pubitemid 46647413)
70. Huang S, Ernberg I and Kauffman S 2009 Cancer attractors: a systems view of tumors from a gene network dynamics and developmental perspective. Semin. Cell Dev. Biol. 20 869-876
71. Iakoucheva LM, Brown CJ, Lawson JD, Obradovic Z and Dunker AK 2002 Intrinsic disorder in cell-signaling and cancer-associated proteins. J. Mol. Biol. 323 573-584 (Pubitemid 35283681)
72. Illmensee K and Mintz B 1976 Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Acad. Natl. Acad. Sci. USA 73 549-53
73. Jiao X, Wood LD, Lindman M, Jones S, Buckhaults P, Polyak K, Sukumar S, Carter H, Kim D, Karchin R and Sjoblom T 2012 Somatic mutations in the Notch, NF-KB, PIK3CA and Hedgehog pathways in human breast cancers. Genes Chromosomes Cancer 51 480-489
74. Kalari S and Pfeifer GP 2010 Identification of driver and passenger DNA methylation in cancer by epigenomic analysis. Adv. Genet. 70 277-308
75. Kaneko K 2006 Life: An introduction to complex systems biology (New York: Springer)
76. Kreso A, O'Brien CA, van Galen P, Gan OI, Notta F, Brown AM, Ng K, Ma J, et al. 2013 Variable clonal repopulation dynamics influence chemotherapy response in colorectal cancer. Science 339 543-548
77. Kuhn TS 2012 The structure of scientific revolutions (Chicago: University of Chicago Press)
78. Kulkarni P, Shiraishi T and Kulkarni RV 2013 Cancer: tilting at windmills? Mol. Cancer 12 108
79. Lapidot T, Sirard C, Vormoor J, Murdoch B, Hoang T, Caceres-Cortes J, Minden M, Paterson B, Caligiuri MA and Dick JE 1994 A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367 645-648 (Pubitemid 24067706)
80. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, et al. 2013 Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499 214-218
81. Li Y and Laterra J 2012 Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res. 72 576-80
82. Longo G, Miquel PA, Sonnenschein C and Soto AM 2012 Is information a proper observable for biological organization? Prog. Biophys. Mol. Biol. 109 108-114
83. Luria SE 1975 36 Lectures in biology (Cambridge: MIT Press)
84. Maenhaut C, Dumont JE, Roger PP and van Staveren WC 2010 Cancer stem cells: a reality, a myth, a fuzzy concept or a misnomer? An analysis. Carcinogenesis 31 149-158
85. Maffini MV, Soto AM, Calabro JM, Ucci AA and Sonnenschein C 2004 The stroma as a crucial target in rat mammary gland carcinogenesis. J. Cell Sci. 117 1495-502 (Pubitemid 38559824)
86. Maffini MV, Calabro JM, Soto AM and Sonnenschein C 2005 Stromal regulation of neoplastic development: age-dependent normalization of neoplastic mammary cells by mammary stroma. Am. J. Pathol. 167 1405-1410 (Pubitemid 41541426)
87. Makarem M, Spike BT, Dravis C, Kannan N, Wahl GM and Eaves CJ 2013 Stem cells and the developing mammary gland. J. Mammary Gland Biol. Neoplasia 18 209-19
88. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, et al. 2008 The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133 704-715 (Pubitemid 351636299)
89. Marshman E, Booth C and Potten CS 2002 The intestinal epithelial stem cell. BioEssays: News Rev. Mol. Cell. Dev. Biol. 24 91-98 (Pubitemid 34108424)
90. Martinez-Climent JA andreu EJ and Prosper F 2006 Somatic stem cells and the origin of cancer. Clin. Transl. Oncol. 8 647-663
91. Marusyk A and Polyak K 2013 Cancer. Cancer cell phenotypes, in fifty shades of grey. Science 339 528-9
92. McKenna ES and Roberts CW 2009 Epigenetics and cancer without genomic instability. Cell Cycle 8 23-26
93. Medina D and Kittrell F 2005 Stroma is not a major target in DMBA-mediated tumorigenesis of mouse mammary preneoplasia. J. Cell Sci. 118 123-127 (Pubitemid 40277110)
94. Milo R, Hou JH, Springer M, Brenner MP and Kirschner MW 2007 The relationship between evolutionary and physiological variation in hemoglobin. Proc. Acad. Natl. Acad. Sci. USA 104 16998-17003 (Pubitemid 350210979)
95. Mintz B and Illmensee K 1975 Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Acad. Natl. Acad. Sci. USA 72 3585-9
96. Morgan CL 1896 On modification and variation. Science 4 733-740
97. Mrozek K, Marcucci G, Paschka P, Whitman SP and Bloomfield CD 2007 Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification? Blood 109 431-448 (Pubitemid 46105936)
98. Mueller MM and Fusenig NE 2004 Friends or foes - bipolar effects of the tumour stroma in cancer. Nat. Rev. Cancer 4 839-849 (Pubitemid 39472951)
99. Mukherjee S 2010 The emperor of all maladies: A biography of cancer (New York: Simon and Schuster)
100. Munoz P, Iliou MS and Esteller M 2012 Epigenetic alterations involved in cancer stem cell reprogramming. Mol. Oncol. 6 620-636
101. Murawska M and Brehm A 2011 CHD chromatin remodelers and the transcription cycle. Transcription 2 244-253
102. Nakagaki T, Yamada H and Toth A 2000 Maze-solving by an amoeboid organism. Nature 407 470
103. Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, Mao JH, Ravani SA, Zavadil J, et al. 2011 Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 19 640-651
104. Nik-Zainal S, Van Loo P, Wedge DC, Alexandrov LB, Greenman CD, Lau KW, Raine K, Jones D, Marshall J and Ramakrishna M 2012 The life history of 21 breast cancers. Cell 149 994-1007
105. Nowell PC 1976 The clonal evolution of tumor cell populations. Science 194 23-28
106. Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD and Cunha GR 1999 Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res. 59 5002-5011 (Pubitemid 29472907)
107. Osborn HF 1896 Oytogenic and phylogenic variation. Science 4 786-789
108. Paranjape AN, Mandal T, Mukherjee G, Kumar MV, Sengupta K and Rangarajan A 2012 Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene 31 1896-1909
109. Pardal R, Clarke MF and Morrison SJ 2003 Applying the principles of stem-cell biology to cancer. Nat. Rev. Cancer 3 895-902 (Pubitemid 37500174)
110. Parr E 2012 The default state of the cell: quiescence or proliferation? BioEssays: News Rev. Mol. Cell. Dev. Biol. 34 36-37
111. Pasternak G, Hochhaus A, Schultheis B and Hehlmann R 1998 Chronic myelogenous leukemia: molecular and cellular aspects. J. Cancer Res. Clin. Oncol. 124 643-660 (Pubitemid 29003297)
112. Patil A, Kinoshita K and Nakamura H 2010 Hub promiscuity in protein-protein interaction networks. Int. J. Mol. Sci. 11 1930-43
113. Perez-Losada J, Gutierrez-Cianca N and Sanchez-Garcia I 2001 Philadelphia-positive B-cell acute lymphoblastic leukemia is initiated in an uncommitted progenitor cell. Leukemia Lymphoma 42 569-576 (Pubitemid 32782762)
114. Pineau P, Ezzikouri S, Marchio A, Benazzouz M, Cordina E, Afifi R, Elkihal L, Khalfallah MT, et al. 2007 Genomic stability prevails in North-African hepatocellular carcinomas. Digest. Liver Dis. 39 671-677 (Pubitemid 46888212)
115. Pitot H and Loeb D 2002 Fundamentals of oncology 4th edition (New York: Marcel Dekker)
116. Portela A and Esteller M 2010 Epigenetic modifications and human disease. Nat. Biotechnol. 28 1057-1068
117. Prehn RT 1994 Cancers beget mutations versus mutations beget cancers. Cancer Res. 54 5296-5300 (Pubitemid 24336016)
118. Quaranta V and Tyson DR 2013 What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity. Sci. Signal 6 32
119. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM and Morrison SJ 2008 Efficient tumour formation by single human melanoma cells. Nature 456 593-598
120. Rajagopalan K, Mooney SM, Parekh N, Getzenberg RH and Kulkarni P 2011 A majority of the cancer/testis antigens are intrinsically disordered proteins. J. Cell. Biochem. 112 3256-67
121. Rangarajan A and Weinberg RA 2003 Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 3 952-959 (Pubitemid 37500180)
122. Rather LJ 1978 The genesis of cancer (Baltimore: Johns Hopkins University Press)
123. Reya T, Morrison SJ, Clarke MF and Weissman IL 2001 Stem cells, cancer and cancer stem cells. Nature 414 105-111
124. Rutherford SL and Lindquist S 1998 Hsp90 as a capacitor for morphological evolution. Nature 396 336-42 (Pubitemid 28557387)
125. Saetzler K, Sonnenschein C and Soto AM 2011 Systems biology beyond networks: generating order from disorder through self-organization. Semin. Cancer Biol. 21 165-174
126. Saigusa T, Tero A, Nakagaki T and Kuramoto Y 2008 Amoebae anticipate periodic events. Phys. Rev. Lett. 100 018101
127. Sandhu KS 2009 Intrinsic disorder explains diverse nuclear roles of chromatin remodeling proteins. J. Mol. Recognit. 22 1-8
128. Satgé D 2013 Analysis of somatic mutations in cancer tissues challenges the somatic mutation theory of cancer (Chichester: John Wiley and Sons, Ltd.)
129. Saxena M, Stephens MA, Pathak H and Rangarajan A 2011 Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters. Cell Death Dis. 2 e179
130. Scheel C and Weinberg RA 2011 Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int. J. Cancer 129 2310-2314
131. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M and Clevers H 2012 Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337 730-735
132. Schmalhausen II 1949 Factors of evolution (Philadelphia, PA: Blakiston)
133. Setoguchi T, Taga T and Kondo T 2004 Cancer stem cells persist in many cancer cell lines. Cell Cycle 3 414-415 (Pubitemid 40278224)
134. Sevim V and Rikvold PA 2008 Chaotic gene regulatory networks can be robust against mutations and noise. J. Theor. Biol. 253 323-332
135. Sfanos KS and De Marzo AM 2012 Prostate cancer and inflammation: the evidence. Histopathology 60 199-215
136. Shachaf CM, Kopelman AM, Arvanitis C, Karlsson A, Beer S, Mandl S, Bachmann MH, Borowsky AD, et al. 2004 MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 1112-1117 (Pubitemid 39472236)
137. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S, McDermott U, Azizian N, et al. 2010 A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141 69-80
138. Sole RV and Deisboeck TS 2004 An error catastrophe in cancer? J. Theor. Biol. 228 47-54 (Pubitemid 38452725)
139. Sonnenschein C and Soto AM 1999 The society of cells: Cancer and control of cell proliferation (New York: Springer Verlag)
140. Sonnenschein C and Soto AM 2013 The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique. J. Biosci. 38 651-63
141. Soto AM and Sonnenschein C 2011 The tissue organization field theory of cancer: a testable replacement for the somatic mutation theory. BioEssays: News Rev. Mol. Cell. Dev. Biol. 33 332-40
142. Soto AM and Sonnenschein C 2012 Is systems biology a promising approach to resolve controversies in cancer research? Cancer Cell Int. 12 12
143. Soto AM and Sonnenschein C 2013 Paradoxes in carcinogenesis: there is light at the end of that tunnel! Disrup. Sci. Technol. 1 154-156
144. Soto AM, Sonnenschein C and Miquel PA 2008 On physicalism and downward causation in developmental and cancer biology. Acta Biotheoretica 56 257-274
145. Soto AM, Sonnenschein C, Maini PK and Noble D 2011 Systems biology and cancer. Prog. Biophys. Mol. Biol. 106 337-9
146. Steward FC, Mapes MO and Smith J 1958 Growth and organized development of cultured cells. I. Growth and division freely suspended cells. Am. J. Bot. 45 693-703
147. Stratton MR, Campbell PJ and Futreal PA 2009 The cancer genome. Nature 458 719-724
148. Suva ML, Riggi N and Bernstein BE 2013 Epigenetic reprogramming in cancer. Science 339 1567-1570
149. Tam WL and Weinberg RA 2013 The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat. Med. 19 1438-1449
150. Tang R, Changchien CR, Wu MC, Fan CW, Liu KW, Chen JS, Chien HT and Hsieh LL 2004 Colorectal cancer without high microsatellite instability and chromosomal instability - an alternative genetic pathway to human colorectal cancer. Carcinogenesis 25 841-846 (Pubitemid 38618539)
151. Tero A, Takagi S, Saigusa T, Ito K, Bebber DP, Fricker MD, Yumiki K, Kobayashi R and Nakagaki T 2010 Rules for biologically inspired adaptive network design. Science 327 439-442
152. Timp W and Feinberg AP 2013 Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat. Rev. Cancer 13 497-510
153. Tompa P and Csermely P 2004 The role of structural disorder in the function of RNA and protein chaperones. FASEB J. 18 1169-1175 (Pubitemid 39006878)
154. Uversky VN 2012 Intrinsically disordered proteins and novel strategies for drug discovery. Expert Opin. Drug Discov. 7 475-488
155. Uversky VN and Dunker AK 2010 Understanding protein nonfolding. Biochim. Biophys. Acta 1804 1231-1264
156. Van Dyke T and Jacks T 2002 Cancer modeling in the modern era: progress and challenges. Cell 108 135-144 (Pubitemid 34161134)
157. Varmus H and Weinberg RA 1993 Genes and the biology of cancer (New York: Scientific American Library)
158. Vaux DL 2011 In defense of the somatic mutation theory of cancer. BioEssays: News Rev. Mol. Cell. Dev. Biol. 33 341-343
159. Vavouri T, Semple JI, Garcia-Verdugo R and Lehner B 2009 Intrinsic protein disorder and interaction promiscuity are widely associated with dosage sensitivity. Cell 138 198-208
160. Vendramini-Costa DB and Carvalho JE 2012 Molecular link mechanisms between inflammation and cancer. Curr. Pharm. Des. 18 3831-3852
161. Visvader JE and Lindeman GJ 2008 Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 8 755-768
162. Vogelstein B and Kinzler KW 2004 Cancer genes and the pathways they control. Nat. Med. 10 789-799 (Pubitemid 39070849)
163. Vogelstein B and Kinzler KW 2012 Winning the war: science parkour. Sci. Transl. Med. 4 127ed2
164. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Jr. and Kinzler KW 2013 Cancer genome landscapes. Science 339 1546-1558
165. Waddington CH 1942 Canalization of development and the inheritance of acquired characters. Nature 150 563-565
166. Watson JD and Crick FH 1953 Molecular structure of nucleic acids; a structure for deoxyribose nucleic acid. Nature 171 737-738
167. Welte Y, Adjaye J, Lehrach HR and Regenbrecht CR 2010 Cancer stem cells in solid tumors: elusive or illusive? Cell Commun. Signal 8 6
168. Wilkins MH, Stokes AR and Wilson HR 1953 Molecular structure of deoxypentose nucleic acids. Nature 171 738-740
169. Zipori D 2004 The nature of stem cells: state rather than entity. Nat. Rev. Genet. 5 873-878 (Pubitemid 39457503)